Loading…
Callan JMB Inc. is projected to decline to $0.674 by 2027, a -7% move from its current price of $0.7213. CJMB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.6799 | $0.7218 | $0.7662 | +0.06% |
| May 30 | $0.6637 | $0.7222 | $0.7859 | +0.13% |
| May 31 | $0.6516 | $0.7227 | $0.8015 | +0.19% |
| Jun 1 | $0.6417 | $0.7231 | $0.8149 | +0.26% |
| Jun 2 | $0.6331 | $0.7236 | $0.827 | +0.32% |
| Jun 3 | $0.6255 | $0.7241 | $0.8382 | +0.38% |
| Jun 4 | $0.6186 | $0.7245 | $0.8486 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6186 | $0.7245 | $0.8486 | +0.45% |
| Week 2 | $0.582 | $0.7278 | $0.9101 | +0.90% |
| Week 3 | $0.556 | $0.731 | $0.9612 | +1.35% |
| Week 4 | $0.5353 | $0.7343 | $1.01 | +1.80% |
| Week 5 | $0.518 | $0.7376 | $1.05 | +2.26% |
| Week 6 | $0.503 | $0.7409 | $1.09 | +2.72% |
| Week 7 | $0.4899 | $0.7442 | $1.13 | +3.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in the United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.
The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. It was founded in 2006 and is headquartered in Spring Branch, Texas.
CJMB is the asset described with current price $0.7213 and a market cap of $4.07M, ranking at 5324. The stock sits in the Industrials category and operates as a life sciences cold-chain logistics provider through its Coldchain Technology Services subsidiary.
The near-term forecast for 2026 shows a min of $0.716, an avg of $0.7213, and a max of $1.07 with a neutral sentiment and 0% ROI, suggesting limited movement around the current price in that year.
Longer-term projections reveal a bear phase in 2030 (min $0.2852, avg $0.4849, max $0.8747; ROI -32.8; sentiment BEARISH) followed by a return to bullish dynamics later in the decade and into the 2040s and 2050s, with 2032/2034/2040/2050 showing positive ROI and higher average prices (2032 avg $0.9365, ROI 29.8; 2034 avg $0.8738, ROI 21.1; 2040 avg $1.30, ROI 79.6; 2050 avg $1.55, ROI 114.5). The forecast also presents a 2040 max of $2.98 and a 2050 max of $3.56, indicating potential long-term upside despite earlier weakness.
A major floor 45.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 66.4% above — a clean break opens room to run.
A major ceiling 440.7% above — clearing it would confirm fresh momentum.
Key CJMB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CJMB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7638 | Sell | $0.7835 | Sell |
| MA 10 | $0.8601 | Sell | $0.8471 | Sell |
| MA 20 | $0.9751 | Sell | $0.9415 | Sell |
| MA 50 | $1.20 | Sell | $1.17 | Sell |
| MA 100 | $1.52 | Sell | $1.58 | Sell |
| MA 200 | $2.63 | Sell | $2.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 28.78 | Buy |
| Stoch RSI (14) | 25.22 | Neutral |
| CCI (20) | -136.66 | Sell |
| Williams %R (14) | -98.82 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -36.75 | Sell |
| Bollinger %B (20,2) | 0.06 | Neutral |
| Stochastic %K (14) | 1.18 | Buy |
| TRIX (15) | -1.29 | Sell |
| Awesome (5,34) | -0.27 | Sell |
| Ultimate (7,14,28) | 22.46 | Buy |
| Momentum (10) | -0.31 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 0.73 | Sell |
| ADX (14) | 30.13 | Sell |
| ATR (14) | 0.05 | Info |
Technical sentiment is NEUTRAL. RSI14 is 30, indicating a relatively oversold reading within the near term. The stock trades with a 50-day simple moving average of $1.20 and a 200-day simple moving average of $2.63, suggesting the price has been below longer-term averages.
The current support is $0.716 and resistance is $1.20, framing a defined near-term range. The 30-day range spans from $0.4865 to $1.07, underscoring limited near-term upside potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.716 | $0.7213 | $1.07 | 0% | Neutral | |
| $0.4745 | $0.674 | $1.04 | -7% | Neutral | |
| $0.4326 | $0.6573 | $1.08 | -9% | Neutral | |
| $0.4064 | $0.6546 | $1.13 | -9% | Neutral | |
| $0.2852 | $0.4849 | $0.8747 | -33% | Bearish | |
| $0.3805 | $0.6805 | $1.27 | -6% | Neutral | |
| $0.4986 | $0.9365 | $1.81 | +30% | Bullish | |
| $0.4254 | $0.8379 | $1.67 | +16% | Neutral | |
| $0.4235 | $0.8738 | $1.78 | +21% | Bullish | |
| $0.37 | $0.7994 | $1.67 | +11% | Neutral | |
| $0.583 | $1.30 | $2.98 | +80% | Bullish | |
| $0.6963 | $1.55 | $3.56 | +115% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.716 | $0.7213 | $0.8581 | +0.00% |
| June 2026 | $0.5953 | $0.7171 | $0.8973 | -0.58% |
| July 2026 | $0.6228 | $0.7645 | $0.9835 | +6.61% |
| August 2026 | $0.65 | $0.8098 | $1.06 | +5.92% |
| September 2026 | $0.6195 | $0.7814 | $1.04 | -3.51% |
| October 2026 | $0.5908 | $0.7537 | $1.02 | -3.54% |
| November 2026 | $0.6019 | $0.7757 | $1.07 | +2.92% |
| December 2026 | $0.5884 | $0.7656 | $1.07 | -1.30% |
Click any year to see its month-by-month CJMB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CJMB to range from $0.716 to $1.07 through 2026. The $0.7213 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CJMB price prediction for 2027 points to an average of $0.674 (low $0.4745, high $1.04) — a potential decline of -7% on today's $0.7213. Price action looks broadly range-bound.
In 2028, CJMB is projected to trade between $0.4326 and $1.08, averaging $0.6573 — a potential decline of -9% from today's $0.7213. That is -2% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Callan JMB Inc.'s 2029 outlook centres on $0.6546, within a $0.4064 to $1.13 range. That is 0% versus the projected 2028 average. That marks a -9% change versus current levels. Price action looks broadly range-bound.
By 2030, CJMB could reach as high as $0.8747, with a base case around $0.4849 and support toward $0.2852 — roughly -33% from $0.7213. Expect choppier, lower action through this leg of the cycle.
Expect CJMB to range from $0.3805 to $1.27 through 2031. The $0.6805 average target implies a -6% move from current prices. That is up +40% on the projected 2030 average. Price action looks broadly range-bound.
The CJMB price prediction for 2032 points to an average of $0.9365 (low $0.4986, high $1.81) — a potential gain of +30% on today's $0.7213. Buyers look set to stay in control over this stretch.
In 2033, CJMB is projected to trade between $0.4254 and $1.67, averaging $0.8379 — a potential gain of +16% from today's $0.7213. That is -11% versus the projected 2032 average. Price action looks broadly range-bound.
Callan JMB Inc.'s 2034 outlook centres on $0.8738, within a $0.4235 to $1.78 range. That is up +4% on the projected 2033 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CJMB could reach as high as $1.67, with a base case around $0.7994 and support toward $0.37 — roughly +11% from $0.7213. Price action looks broadly range-bound.
Expect CJMB to range from $0.583 to $2.98 through 2040. The $1.30 average target implies a +80% move from current prices. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CJMB price prediction for 2050 points to an average of $1.55 (low $0.6963, high $3.56) — a potential gain of +115% on today's $0.7213. Momentum favours further upside here.
Investing $1,000 in CJMB today (≈ 1,386.385692 CJMB) could be worth
$2,145.21
+$1,145.21 (+115%) by 2050 · US Dollar
Based on the average projected CJMB price of $1.55 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CJMBwould be worth at today's price.
$1,000 invested in CJMB on May 27, 2025 (≈ 184.433791 CJMB) would be worth
$133.03
-$866.97 (-86.7%) today · 0.13× · US Dollar
Based on a CJMB entry price of $5.42 vs. today's $0.7213.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.716 | $1,007.4 | +0.7% |
| 1 month ago | $0.982 | $734.52 | -26.5% |
| 3 months ago | $1.63 | $442.52 | -55.7% |
| 6 months ago | $2.5 | $288.52 | -71.1% |
| 1 year ago | $5.42 | $133.03 | -86.7% |
| All time (1.3y) ago | $4.1 | $175.93 | -82.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CJMB forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $7.9M
The multi-year forecast shows a bear phase in 2030, with an average price of $0.4849 and a range from $0.2852 to $0.8747, corresponding to a -32.8% ROI. This is followed by a shift toward bullish conditions in 2032 with an average of $0.9365 (ROI 29.8), and continued strength into 2034 ($0.8738, ROI 21.1) and 2040 ($1.30, ROI 79.6). By 2050, the average is projected to $1.55 with an ROI of 114.5, and a max price projection of $3.56.
These figures imply meaningful long-term upside after a mid-cycle downturn, albeit with notable volatility reflected in 100% annualized volatility. Overall, these are estimates, not guarantees, and the long horizon carries both potential gains and downside risk.
Tap a question to reveal the answer.
2030 forecast: avg $0.4849 with min $0.2852 and max $0.8747; ROI -32.8; sentiment BEARISH.
Long-term projections show potential upside with 2040 avg $1.30 (ROI 79.6) and 2050 avg $1.55 (ROI 114.5), but 2030 is bearish (avg $0.4849; ROI -32.8). These are estimates, not guarantees, and carry significant uncertainty.
Yes, the forecast includes a 2040 max of $2.98 and a 2050 max of $3.56, suggesting potential to approach the $3 mark in the longer term, even as averages indicate more modest near-term levels.
Current price is $0.7213 and market cap is $4.07M; CJMB ranks 5324.
Near term shows neutral sentiment with RSI 30, support at $0.716 and resistance at $1.20, and a 30-day range of $0.4865 to $1.07. The long-term view is volatile, with a bear phase in 2030 and bullish momentum later, and annualized volatility at 100%.
Callan JMB Inc. Community Discussion
0Share your Callan JMB Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.